Foley, Jason E <br/><br/>
Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Nov 2005 
 - 5732-43 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>0022-1767 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.175.9.5732  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Bone Marrow Transplantation--immunology<br/>Graft vs Host Disease--prevention & control<br/>Graft vs Tumor Effect--drug effects<br/>Immunosuppressive Agents--pharmacology<br/>Interleukin-4--physiology<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Inbred C57BL<br/>Sirolimus--pharmacology<br/>Th2 Cells--drug effects<br/>Tissue Donors